Kaplan–Meier analysis revealed that high expression of NgBR was associated with poor RFS in patients with ERα-positive breast cancer (n = 755) and in patients receiving endocrine therapy (n = 335) (Fig. 7b; Additional files 6, 7, 8 and 9). This evidence concerns the gene ESR1 and breast cancer.